A look into the less discussed therapeutic aspect of psychedelics: the anti-inflammatory effect.
As psychedelic research moves ahead, some have started to identify several topics of significant interest to women.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.
The center is the first of its kind in the US and will propel psychedelic research to a new level.
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.
The evidence points to several possibilities. It could be psilocybin or a combination of factors.
More and more women are self-treating with psychedelics to relieve their symptoms.
The serotonin 5-HT2C receptor may play a key role.
In spite of the hype, a new Imperial College study says the jury is still out.
There’s nausea, paralysis, and fatigue to name a few.